FLT1 and type 1 diabetes mellitus: A longitudinal analysis of 157 women with T1DM enrolled in the CONCEPTT trial assessed the placental function at baseline and again at 24- and 34-weeks' gestation by measuring placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt-1) (17).